Tg(Amigo2-icre/ERT2)2Ehs
Transgene Detail
|
|
| Symbol: |
Tg(Amigo2-icre/ERT2)2Ehs |
| Name: |
transgene insertion 2, National Institute of Environmental Health Science |
| MGI ID: |
MGI:6754159 |
| Transgene: |
Tg(Amigo2-icre/ERT2)2Ehs Location: unknown
|
| Alliance: |
Tg(Amigo2-icre/ERT2)2Ehs page
|
|
| Strain of Origin: |
C57BL/6 x SJL
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(Amigo2-icre/ERT2)2Ehs expression driven by
1 gene
Transgene expression driven by:
|
| |
|
Mutation details: The BAC clone RP23-288P18 was modified with recombineering techniques so that an icreERT2 is driven by the Amigo2 promotor. The Amigo2 ATG was replaced with the icre ATG preceded with a perfect KOZAK sequence. At the 3 end of the icreERT2 cassette, a synthetic bovine growth hormone (BGH) polyadenylation signal was added after the STOP codon. For the selection of recombined BACs, a flippase-site flanked neomycin resistance gene was incorporated into the targeting fragment following the icreERT2 cassette. Recombined BACs without the neo marker were linearized and purified and microinjected into pronuclei of B6SJLF1 mouse oocytes. Six independent founder mice resulted. Two lines showing adult expression of icreERT2 in CA2 were established. This is line 2 of two lines. This line showed expression of Cre in CA2 as well as sparse expression in the dentate gyrus, fasciola cinerea and hypothalamus.
(J:288826)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
Amigo2
(mouse)
|
| |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:288826 Alexander GM, et al., CA2 neuronal activity controls hippocampal low gamma and ripple oscillations. Elife. 2018 Nov 2;7:e38052 |
| All: |
1 reference(s) |
|
Analysis Tools
